Literature DB >> 10438846

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.

M M McNeal1, M N Rae, J A Bean, R L Ward.   

Abstract

The ability to elicit protective immune responses after intranasal immunization with rotavirus particles, either with or without the attenuated Escherichia coli heat-labile enterotoxin LT(R192G) as an adjuvant, was examined in the adult mouse model. BALB/c mice were administered one or two inoculations of psoralen/UV-inactivated, triple-layered (tl) or double-layered (dl) purified rotavirus particles. Four weeks after immunization, mice were challenged with the murine rotavirus strain EDIM, and the shedding of rotavirus antigen was quantified. Rotaviruses used for immunization included EDIM and heterotypic simian (RRV), bovine (WC3), and human (89-12) strains. tl EDIM stimulated both systemic and intestinal rotavirus antibody responses and complete protection with as little as one 1-microgram dose. Inclusion of LT(R192G) (10 micrograms) significantly increased rotavirus antibody responses and reduced antigen concentrations needed for full protection. Both dl EDIM and heterotypic dl and tl particles stimulated protection, but they did so less than tl EDIM at comparable concentrations, either with or without LT(R192G). When B-cell-deficient microMt mice were immunized with tl EDIM particles, protection was reduced to levels similar to those induced with dl EDIM and heterotypic particles in BALB/c mice. However, dl EDIM particles induced similar levels of protection in both mouse strains. The protection stimulated by tl or dl EDIM particles was not diminished by CD8 cell depletion prior to immunization in either strain of mice. These results indicate that tl EDIM induced immunity at least partially through responses to its outer capsid proteins, presumably by stimulation of serotype-specific neutralizing antibody. In contrast, the other particles stimulated protection primarily by an antibody-independent mechanism. Finally, depletion of CD8 cells had no effect on protection by either mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438846      PMCID: PMC104283          DOI: 10.1128/JVI.73.9.7565-7573.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Vaccine developments.

Authors:  M A Liu
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system.

Authors:  P Weisz-Carrington; M E Roux; M McWilliams; J M PHILLIPS-Quagliata; M E Lamm
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

4.  Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.

Authors:  D I Bernstein; V E Smith; D S Sander; K A Pax; G M Schiff; R L Ward
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

5.  The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens.

Authors:  N Lycke; U Karlsson; A Sjölander; K E Magnusson
Journal:  Scand J Immunol       Date:  1991-06       Impact factor: 3.487

6.  Development of an adult mouse model for studies on protection against rotavirus.

Authors:  R L Ward; M M McNeal; J F Sheridan
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21.

Authors:  M M McNeal; M N Rae; M E Conner; R L Ward
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

8.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

10.  A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population.

Authors:  M Santosham; G W Letson; M Wolff; R Reid; S Gahagan; R Adams; C Callahan; R B Sack; A Z Kapikian
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  24 in total

1.  Functional mapping of protective domains and epitopes in the rotavirus VP6 protein.

Authors:  A H Choi; M Basu; M M McNeal; J Flint; J L VanCott; J D Clements; R L Ward
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

3.  Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype.

Authors:  Monica M McNeal; Karol Sestak; Anthony H-C Choi; Mitali Basu; Michael J Cole; Pyone P Aye; Rudolf P Bohm; Richard L Ward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.

Authors:  Nathalie Parez; Cynthia Fourgeux; Ali Mohamed; Catherine Dubuquoy; Mathieu Pillot; Axelle Dehee; Annie Charpilienne; Didier Poncet; Isabelle Schwartz-Cornil; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams.

Authors:  Alexander J Bondoc; Mubeen A Jafri; Bryan Donnelly; Sujit K Mohanty; Monica M McNeal; Richard L Ward; Greg M Tiao
Journal:  J Pediatr Surg       Date:  2009-08       Impact factor: 2.545

6.  Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.

Authors:  Audrey Glynn; Chad J Roy; Bradford S Powell; Jeffrey J Adamovicz; Lucy C Freytag; John D Clements
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.

Authors:  Ming Xia; Pengwei Huang; Xi Jiang; Ming Tan
Journal:  Vaccine       Date:  2019-06-11       Impact factor: 3.641

8.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

9.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.

Authors:  Suvi Lappalainen; Kirsi Tamminen; Timo Vesikari; Vesna Blazevic
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.